Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Room Temperature Monitoring in Sample Collection Areas – V 2.0

Posted on By

BA-BE Studies: SOP for Room Temperature Monitoring in Sample Collection Areas – V 2.0

Standard Operating Procedure for Room Temperature Monitoring in Sample Collection Areas during BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/089/2025
Supersedes SOP/BA-BE/089/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a standardized method for the monitoring, recording, and reviewing of ambient room temperature in sample collection areas during the conduct of Bioavailability/Bioequivalence (BA/BE) studies to maintain sample integrity and ensure protocol compliance.

2. Scope

This SOP applies to all clinical staff involved in biological sample collection, handling, and pre-processing in designated sample collection areas at clinical research facilities conducting BA/BE studies.

3. Responsibilities

  • Clinical Research Coordinator (CRC): Ensures routine temperature monitoring and log maintenance.
  • Study Nurse: Records temperature at defined intervals during study procedures.
  • QA Officer: Periodically audits the temperature records and calibrations.
See also  BA-BE Studies: SOP for Preparing Clinical Investigator’s Brochure (CIB) - V 2.0

4. Accountability

The Site Operations Manager is accountable for ensuring that environmental monitoring is performed as per protocol and any deviations are promptly investigated and resolved.

5. Procedure

5.1 Equipment Setup

  1. Install calibrated digital room thermometers or continuous data loggers in each sample collection area.
  2. Place devices at an appropriate height, away from direct sunlight, doors, and air vents.
  3. Ensure calibration certificate is valid and available (Annexure-1).

5.2 Monitoring Frequency

  1. During study conduct, record room temperature:
    • Hourly during sample collection periods
    • Before initiation of sample collection and after completion
  2. Use Annexure-2: Room Temperature Log Sheet for manual entries.

5.3 Temperature Limits and Alert Range

  1. Acceptable temperature range: 20°C to 25°C ±2°C (unless specified by protocol).
  2. If temperature goes outside the specified range:
    • Immediately inform the CRC and PI
    • Document deviation in Annexure-3: Environmental Deviation Log
    • Implement immediate corrective action such as adjusting HVAC or relocating samples
See also  BA-BE Studies: SOP for Informed Consent Process Execution - V 2.0

5.4 Data Logger Use (If Applicable)

  1. Download electronic logs at the end of the study day or session.
  2. Review for any temperature excursions and archive records in eTMF or site file.

5.5 Record Review and Archiving

  1. QA team to review completed temperature logs weekly or at study close-out.
  2. All temperature logs must be archived in the Trial Master File (TMF) for a minimum of 5 years.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • CRC: Clinical Research Coordinator
  • QA: Quality Assurance
  • HVAC: Heating, Ventilation, and Air Conditioning
  • TMF: Trial Master File

7. Documents

  1. Calibration Certificate – Annexure-1
  2. Room Temperature Log Sheet – Annexure-2
  3. Environmental Deviation Log – Annexure-3

8. References

  • ICH E6(R2) – Good Clinical Practice
  • Study Protocols for BA/BE Studies
  • WHO Guidelines on Good Clinical Laboratory Practice (GCLP)
See also  BA-BE Studies: SOP for Maintaining Investigator Site File (ISF) - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Calibration Certificate

Device ID Last Calibration Date Next Due Date Calibrated By
THERMO-089 10/03/2025 10/03/2026 Rajesh Instruments

Annexure-2: Room Temperature Log Sheet

Date Time Temperature (°C) Recorded By Remarks
17/04/2025 08:00 23.1 Nisha Verma Within Range

Annexure-3: Environmental Deviation Log

Date Time Temperature Recorded Deviation Corrective Action Reported To
17/04/2025 13:00 27.5°C Above limit HVAC adjusted CRC & QA

Revision History:

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial Release New SOP QA Head
17/04/2025 2.0 Added Annexures and deviation handling section Audit Observation QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: API Manufacturing: SOP for Moisture Content Analysis by LOD – V 2.0
Next Post: Creams: SOP for pH Testing of Cream Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version